AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Highlights
- Goodman Group sees modest returns amid valuation concerns
- Sonic Healthcare faces profit drop despite revenue growth
- Both companies remain part of broader ASX300 landscape
Two notable names on the ASX300 index, Goodman Group (ASX:GMG) and Sonic Healthcare (ASX:SHL), have recently come into focus among Australian investors tracking large-cap performers. While both companies remain prominent players in their respective industries, recent price movements and financial metrics offer insight into how they’re positioned in 2025.
Since the start of this year, Goodman Group (GMG) has experienced a 14.2% drop in share price. As the largest listed property group on the Australian Securities Exchange, Goodman operates globally across regions such as Australia, the UK, Japan, and the US. The company’s core focus is on developing and managing industrial properties like logistics facilities and warehouses.
Financially, Goodman remains on stable ground with a debt-to-equity ratio of 21.2% as of FY24, indicating a strong capital structure. However, its return on equity (ROE) sits at just 0.1%, which is relatively low for a mature business. Over the past five years, it has delivered an average dividend yield of 1.3%—a consideration for those exploring reliable ASX dividend stocks.
Meanwhile, Sonic Healthcare (ASX:SHL), a major name in the global pathology and diagnostics space, is trading 10.4% below its 52-week high. With operations in Australia, Europe, North America, and New Zealand, the company has diversified its services into diagnostic imaging, general practice medicine, and corporate healthcare solutions.
In the past three years, Sonic's revenue has edged up at a modest rate of 0.8% annually, reaching $8.97 billion in FY24. However, net profit has seen a sharp decline from $1.3 billion to $511 million, and its ROE currently stands at 6.8%. These figures highlight a mixed performance trend as the business navigates cost pressures and post-pandemic market shifts.
Both companies are part of the broader ASX300 index, which tracks Australia's top 300 listed entities. The current data points from GMG and SHL illustrate the diverse dynamics at play within the index—from property sector headwinds to evolving healthcare demands.
While neither company is without its challenges, their ongoing role in the ASX300 underscores their importance within Australia’s corporate landscape.
